Biểu đồ giá cổ phiếu NXGL
NXGL Dự đoán giá cổ phiếu
Nexgel Inc
$0.33
-17.51%
$-0.07
Khi đóng cửa: Aug 06, 16:00:00 GMT-4
$0.33
0%
$0
Phiên trước giờ: Aug 07, 06:55:41 GMT-4
Quay lại
Nexgel Inc (NXGL) Dự đoán giá cổ phiếu
Thống kê chính
Giá đóng cửa trước
$0.411
Giá mở cửa
$0.4052
Phạm vi ngày
$0.3303 - $0.4052
Phạm vi 52 tuần
$0.339 - $2.88
Khối lượng
381.7K
Khối lượng trung bình
404.4K
Tỷ suất cổ tức
--
EPS (TTM)
-0.40
Vốn hóa thị trường
$3.1M
NXGL là gì?
NexGel, Inc. engages in the manufacture of aqueous polymer hydrogels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company is headquartered in Langhorne, Pennsylvania and currently employs 19 full-time employees. The company went IPO on 2021-12-22. The company is engaged in manufacturing high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The firm operates through two segments: NexGel and CGN. Its Nexgel segment comprises the manufacturing of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, which is based in Langhorne, Pennsylvania. Its CGN segment comprises is comprised of the CGN JV used for the Company’s converting and packaging business, which is based in Granbury, Texas. Its brands include Silverseal, Hexagels, Turfguard, Kenkoderm, and Silly George. The company also holds a portfolio of regenerative biomaterials which include Biovance, Biovance 3L, Natalin, and others.
